Concepedia

Copayment Structure Design

Copayment Structure Design is a prescriptive framework within formulary design that specifies the systematic allocation of patient cost-sharing amounts for prescription drugs, differentiated by its focus on structuring tiered copayment levels to influence medication selection, utilization, and cost efficiency.

29

Publications

1.3K

Citations

109

Authors

59

Institutions

Publications per year

2017–2026

3

Parents

Publications

29

The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending

Haiden A. Huskamp, Patricia A. Deverka, Arnold M. Epstein et al. · New England Journal of Medicine · 2003 · 336 citations · Full text

, , +17

Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.

Dana P. Goldman, Geoffrey Joyce, Pinar Karaca‐Mandic · PubMed · 2006 · 165 citations

, , +16

Impact of 3-Tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children

Haiden A. Huskamp, Patricia A. Deverka, Arnold M. Epstein et al. · Archives of General Psychiatry · 2005 · 71 citations · Full text

, , +17

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs

Kathleen A. Fairman, Brenda R. Motheral, Rochelle Henderson · Clinical Therapeutics · 2003 · 70 citations

, , +16

Tier 4 Drugs and the Fraying of the Social Compact

Thomas H. Lee, Ezekiel Emanuel · New England Journal of Medicine · 2008 · 67 citations

, , +17

1–5 of 29

Authors

109

  1. PW
    Pamela Wolfe

    University of Colorado Denver, United States

    3 publications · 87 citations

    3

    h-index

  2. KV
    Kavita V. Nair

    University of Colorado Anschutz Medical Campus, United States

    3 publications · 87 citations

    3

    h-index

  3. GJ
    Geoffrey Joyce

    RAND Corporation, United States

    2 publications · 178 citations

    2

    h-index

  4. RS
    Robert S. Epstein

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 407 citations

    2

    h-index

  5. KA
    Kimberly A. McGuigan

    RAND Corporation, United States

    2 publications · 407 citations

    2

    h-index

1–5 of 109

Institutions

59

  1. Harvard University

    Cambridge, United States

    2 h-index

    3 publications

    743 citations

  2. RAND Corporation

    Santa Monica, United States

    2 h-index

    4 publications

    508 citations

  3. University of Colorado Health

    Aurora, United States

    2 h-index

    5 publications

    185 citations

  4. University of Iowa

    Iowa City, United States

    2 h-index

    2 publications

    71 citations

  5. University of Colorado Denver

    Denver, United States

    2 h-index

    5 publications

    102 citations

  6. University of Denver

    Denver, United States

    1 h-index

    1 publications

    16 citations

  7. Portland State University

    Portland, United States

    1 h-index

    1 publications

    47 citations

  8. Novartis (United States)

    New York, United States

    1 h-index

    1 publications

    13 citations

1–8 of 59

Venues

  1. Journal of Managed Care Pharmacy

    JMCP · 6 publications · 139 citations

    6

    h-index

  2. PubMed

    Repository · 4 publications · 243 citations

    4

    h-index

  3. Health Affairs

    3 publications · 82 citations

    3

    h-index

  4. Journal of Managed Care & Specialty Pharmacy

    JMCP · 2 publications · 60 citations

    2

    h-index

  5. New England Journal of Medicine

    NEJM · 2 publications · 403 citations

    2

    h-index

1–5